drugset
drugset / Trial / NCT00032942

Lofexidine for Opiate Withdrawal - 1

NCT00032942 ↗

Phase 3 Completed 66 enrolled National Institute on Drug Abuse (NIDA) Britannia Pharmaceuticals Ltd. · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate lofexidine for opiate withdrawal.

Timeline

Start
2001-04
Primary completion
2004-10
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject Lofexidine Small molecule — —

Indications

opiate dependence